Distribuzione geografica
Continente #
NA - Nord America 4343
EU - Europa 319
AF - Africa 209
AS - Asia 42
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
OC - Oceania 1
Totale 4918
Nazione #
US - Stati Uniti d'America 4306
NG - Nigeria 209
FR - Francia 119
NL - Olanda 54
IT - Italia 42
GB - Regno Unito 41
CA - Canada 37
DE - Germania 26
BE - Belgio 18
FI - Finlandia 12
IL - Israele 12
TR - Turchia 9
CN - Cina 5
SG - Singapore 4
IN - India 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
RO - Romania 2
SE - Svezia 2
TH - Thailandia 2
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
HK - Hong Kong 1
IQ - Iraq 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
TW - Taiwan 1
UA - Ucraina 1
VN - Vietnam 1
Totale 4918
Città #
Wilmington 1206
Chandler 1148
San Mateo 514
Ann Arbor 294
Lawrence 210
Princeton 210
Benin City 209
Leawood 196
Fairfield 121
Paris 119
Boardman 104
Woodbridge 90
Amsterdam 54
London 40
San Diego 39
Seattle 38
Toronto 36
Norwalk 24
Milan 22
Brussels 18
Abbiategrasso 12
Helsinki 12
Redmond 11
Kocaeli 9
Houston 5
Redwood City 5
Des Moines 4
Monmouth Junction 4
Clearwater 3
Falls Church 3
Frankfurt am Main 3
Hanover 3
Madison 2
Nanjing 2
Phoenix 2
San Francisco 2
Atlanta 1
Bangkok 1
Basel 1
Basra 1
Beijing 1
Cambridge 1
Catania 1
Coimbatore 1
Crema 1
Dalsjoefors 1
Florence 1
Göttingen 1
Hanoi 1
Kumar 1
La Jolla 1
Leipzig 1
Neubrandenburg 1
New York 1
Padova 1
Seoul 1
Shibuya 1
Sofia 1
Stockholm 1
Sydney 1
Taipei 1
Zanjan 1
Zhengzhou 1
Totale 4801
Nome #
Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma. 44
Amplification of SKI is a prognostic marker in early colorectal cancer 40
Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma 39
Y chromosome loss is a frequent early event in urothelial bladder cancer. 39
Local recurrence in mismatch repair-proficient colon cancer predicted by an infiltrative tumor border and lack of CD8+ tumor-infiltrating lymphocytes 38
AMACR expression in colorectal cancer is associated with left-sided tumor localization 38
HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma 38
Immunophenotyping and oncogene amplifications in tumors of the papilla of Vater 38
Autoimmune hepatitis 37
Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome. 36
Chromosomal instability in gastric mucosa-associated lymphoid tissue lymphomas: a fluorescent in situ hybridization study using a tissue microarray approach 36
Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater. 36
Bioptic diagnosis of chronic hepatitis. Results of an evidence-based consensus conference of the German Society of Pathology, of the German Society for Digestive and Metabolic Diseases and of Compensated Hepatitis (HepNet) 36
Clinicopathological and protein characterization of BRAF and K-RAS mutated colorectal cancer and implications for prognosis. 35
Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis 35
Characterization of rectal, proximal and distal colon cancers based on clinico-pathological, molecular and protein profiles. 35
Role of APAF-1, E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer 34
Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer 34
ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients. 34
Autoimmune hepatitis: overlap syndromes 34
Interferon signaling and treatment outcome in chronic hepatitis C 33
Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I. 33
High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models 33
Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues : a tissue microarray analysis on 4,387 tissue samples 32
MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies. 32
Are the Mallory bodies and intracellular hyaline bodies in neoplastic and non-neoplastic hepatocytes related? 32
Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer 32
CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells 32
Childhood Dietary Intake in Italy: The Epidemiological "MY FOOD DIARY" Survey 32
Disruption of Notch1 Induces Vascular Remodeling, Intussusceptive Angio-genesis, and Angiosarcomas in Livers of Mice. 32
Changes of the hepatic proteome in hepatitis B-infected mouse model at early stages of fibrosis 32
Human aldehyde oxidase 1 interacts with ATP-binding cassette transporter-1 and modulates its activity in hepatocytes 31
Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Re-sponse Than IL28B Genotype in Patients With Hepatitis C. 31
Role of the VEGF ligand to receptor ratio in the progression of mismatch re-pair-proficient colorectal cancer. 31
Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C 31
Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma. 31
Liver precancerous lesions and hepatocellular carcinoma: the histology report. 31
Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis 30
Predicting Fibrosis Worsening in Obese Patients With NASH Through Paren-chymal Fibronectin, HOMA-IR, and Hypertension. 30
Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions 30
Validation of an Extension of the International Non-Invasive Criteria for the Diagnosis of Hepatocellular Carcinoma to the Characterisation of Macroscopic Portal Vein Thrombosis. 30
Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers. 30
Expression and functional role of a transcribed noncoding RNA with an ultra-conserved element in hepatocellular carcinoma. 30
Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression 29
Mechanisms of venoocclusive disease resulting from the combination of cyclophosphamide and roxithromycin 29
Two-marker protein profile predicts poor prognosis in patients with early rectal cancer 29
Abstract Chronic hepatitis C in childhood: an 18-year experience 29
Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness. 29
Hepatitis with Fibrin-Ring Granulomas 29
Parallel determination of NeuroD1, chromogranin-A, KI67 and androgen re-ceptor expression in surgically treated prostate cancers. 29
The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma 29
TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal can-cer. 29
Deregulated HOX genes in ameloblastomas are located in physical contiguity to keratin genes. 29
Hepatic veno-occlusive disease associated with immunosuppressive cyclophosphamide dosing and roxithromycin 29
SMAD7 is a prognostic marker in patients with colorectal cancer 28
Skp2 expression is associated with high risk and elevated Ki67 expression in gastrointestinal stromal tumours 28
Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer 28
Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer 28
Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase 28
Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer. 28
Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice 28
The HOX gene network in hepatocellular carcinoma 28
Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer 28
Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6 28
MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients 27
Toxicity of valproic acid in mice with decreased plasma and tissue carnitine stores 27
HER2, TOP2A, CCND1, EGFR, And C-MYC oncogene amplification in colorectal cancer 27
Cystic lymphangioma associated with enteric duplication as a cause of recurrent vomiting 27
Enzyme histochemical diagnosis of gastrointestinal motility disorders. A laboratory guide 27
Enzyme histochemistry of classical and ultrashort Hirschsprung's disease 27
Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach 27
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients 27
Interleukin 6 is important for survival after partial hepatectomy in mice 27
Patterns of liver infiltration in lymphoproliferative disease 27
Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN). 27
Overexpression of cell division cycle 7 homolog is associated with gene ampli-fication frequency in breast cancer. 27
Homeobox genes in normal and abnormal vasculogenesis 27
Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis 27
Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years 27
Normal erythropoiesis but severe polyposis and bleeding anemia in Smad4-deficient mice 27
Everolimus augments the effects of sorafenib in a syngeneic orthotopic model of hepatocellular carcinoma. 27
Downregulation of renal endothelin-converting enzyme 2 expression in early autoimmune diabetes 26
Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non-Small-Cell Lung Cancer Patients 26
Pax-5 immunoexpression in various types of benign and malignant tumors: a high-throughput tissue microarray analysis 26
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers 26
DCR3 locus is a predictive marker for 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer 26
The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas 26
Immunophenotyping analysis in invasive micropapillary carcinoma of the breast: Role of CD24 and CD44 isoforms expression. 26
Is the improved prognosis of p16 positive oropharyngeal squamous cell carci-noma dependent of the treatment modality? 26
RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis 26
Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers 26
High incidence of EMMPRIN expression in human tumors 25
Elevated Expression of the Tyrosine Phosphatase SHP-1 Defines a Subset of High-Grade Breast Tumors. 25
Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancer. 25
The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients. 25
HER2 gene status in primary breast cancers and matched distant metastases 25
Cytogenetic alterations in liver cell tumors as detected by comparative genomic hybridization 24
Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples 24
Prognostic and predictive relevance of DNAM-1, SOCS6 and CADH-7 genes on chromosome 18q in colorectal cancer 24
Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c 24
Totale 2996
Categoria #
all - tutte 25039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25039

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0000 00 00 00014
2020/20212258 4656 7688 431113 4373044253
2021/2022935 26913269 413 26159 773024069
2022/20231927 458124342354 328311 100 0000
Totale 5134